Smulevich Ab

1.8k total citations · 1 hit paper
72 papers, 1.3k citations indexed

About

Smulevich Ab is a scholar working on Psychiatry and Mental health, Philosophy and Clinical Psychology. According to data from OpenAlex, Smulevich Ab has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Psychiatry and Mental health, 28 papers in Philosophy and 17 papers in Clinical Psychology. Recurrent topics in Smulevich Ab's work include Mental Health and Psychiatry (28 papers), Schizophrenia research and treatment (21 papers) and Psychosomatic Disorders and Their Treatments (19 papers). Smulevich Ab is often cited by papers focused on Mental Health and Psychiatry (28 papers), Schizophrenia research and treatment (21 papers) and Psychosomatic Disorders and Their Treatments (19 papers). Smulevich Ab collaborates with scholars based in Russia, United States and Germany. Smulevich Ab's co-authors include Ferenc Martényi, Darryle D. Schoepp, А С Аведисова, В А Точилов, Bryan G. Johnson, L. M. Bardenstein, Andreev Bv, Sergey Mosolov, Lu Zhang and Morozova Ma and has published in prestigious journals such as Nature Medicine, The British Journal of Psychiatry and Schizophrenia Bulletin.

In The Last Decade

Smulevich Ab

67 papers receiving 1.2k citations

Hit Papers

Activation of mGlu2/3 receptors as a new approach to trea... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
    2007 790 citations Lu Zhang, Ferenc Martényi et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Smulevich Ab Russia 11 596 517 428 182 153 72 1.3k
Morozova Ma Russia 13 711 1.2× 628 1.2× 550 1.3× 230 1.3× 184 1.2× 64 1.5k
Don Goff United States 10 471 0.8× 596 1.2× 300 0.7× 161 0.9× 338 2.2× 13 1.3k
А С Аведисова Russia 9 597 1.0× 274 0.5× 421 1.0× 185 1.0× 168 1.1× 40 1.1k
Anne‐Noël Samaha Canada 22 892 1.5× 456 0.9× 389 0.9× 97 0.5× 246 1.6× 42 1.4k
Teresa Tallerico Canada 17 957 1.6× 465 0.9× 706 1.6× 113 0.6× 178 1.2× 23 1.5k
Philip Seeman Canada 14 779 1.3× 865 1.7× 556 1.3× 102 0.6× 182 1.2× 16 1.7k
H. Lôo France 21 408 0.7× 661 1.3× 209 0.5× 150 0.8× 191 1.2× 72 1.3k
Kaj Forslund Sweden 18 514 0.9× 501 1.0× 326 0.8× 128 0.7× 143 0.9× 31 1.4k
Lisa D. Kochan United States 10 589 1.0× 433 0.8× 346 0.8× 124 0.7× 364 2.4× 11 1.1k
George Garibaldi Switzerland 12 249 0.4× 559 1.1× 221 0.5× 195 1.1× 164 1.1× 21 1000

Countries citing papers authored by Smulevich Ab

Since Specialization
Citations

This map shows the geographic impact of Smulevich Ab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smulevich Ab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smulevich Ab more than expected).

Fields of papers citing papers by Smulevich Ab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smulevich Ab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smulevich Ab. The network helps show where Smulevich Ab may publish in the future.

Co-authorship network of co-authors of Smulevich Ab

This figure shows the co-authorship network connecting the top 25 collaborators of Smulevich Ab. A scholar is included among the top collaborators of Smulevich Ab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smulevich Ab. Smulevich Ab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ab, Smulevich, et al.. (2024). Schizophrenia spectrum disorders (aspects of psychopathology and clinical taxonomy). S S Korsakov Journal of Neurology and Psychiatry. 124(7). 7–7.
2.
Klyushnik, T. P., et al.. (2023). Clinical and Immunological Aspects of Delusional Disorders in Paranoid Schizophrenia. Psikhiatriya. 21(2). 6–16. 2 indexed citations
3.
Ab, Smulevich, et al.. (2021). History and current state of the problem of negative disorders (research of nosological period). S S Korsakov Journal of Neurology and Psychiatry. 121(2). 122–122. 4 indexed citations
4.
Ab, Smulevich, et al.. (2021). Glossalgia as a psychodermatological syndrome. S S Korsakov Journal of Neurology and Psychiatry. 121(7). 7–7. 2 indexed citations
5.
Ab, Smulevich, et al.. (2020). Cariprazine in schizophrenia with predominantly negative symptoms: early effects of therapy (observational study). S S Korsakov Journal of Neurology and Psychiatry. 120(12). 67–67. 3 indexed citations
6.
Ab, Smulevich, et al.. (2020). Negative and positive disorders of schizophrenia (issues of co-dependence, psychopathology and pathogenesis). S S Korsakov Journal of Neurology and Psychiatry. 120(6). 13–13. 6 indexed citations
7.
Ab, Smulevich, et al.. (2017). «Verschroben»-phenomenon in schizophrenia and schizophrenia spectrum disorders: aspects of systematics. S S Korsakov Journal of Neurology and Psychiatry. 117(1). 5–5. 9 indexed citations
8.
Ab, Smulevich, et al.. (2017). Evolution of the schizophrenic deficit concept. S S Korsakov Journal of Neurology and Psychiatry. 117(9). 4–4. 11 indexed citations
9.
Ab, Smulevich. (2016). Schizophrenia spectrum disorders in general medical practice. S S Korsakov Journal of Neurology and Psychiatry. 116(1). 4–4. 7 indexed citations
10.
Ab, Smulevich, et al.. (2016). Efficiency of Umbilical Cord Blood Cells in Patients with Treatment-Resistant Depressions. Bulletin of Experimental Biology and Medicine. 160(4). 583–588. 2 indexed citations
11.
Ab, Smulevich. (2015). Schizophrenia or a group of endogenous diseases? The past and the present. S S Korsakov Journal of Neurology and Psychiatry. 115(8). 4–4. 6 indexed citations
12.
Ab, Smulevich, et al.. (2015). Comorbidity of depression and nonaffective — schizophrenia spectrum disorders: the clinical-epidemiological study EDIP. S S Korsakov Journal of Neurology and Psychiatry. 115(11. Vyp. 2). 6–6. 4 indexed citations
13.
Ab, Smulevich, et al.. (2014). Stress-induced dissociation in the trajectory of schizotypal personality disorder (on the model of nosogenias in oncologic patients). S S Korsakov Journal of Neurology and Psychiatry. 114(12). 12–12. 7 indexed citations
14.
Ab, Smulevich, А. N. Lvov, & Д. В. Романов. (2014). Hypochondriasis Circumscripta: A Neglected Concept with Important Implications in Psychodermatology. Acta Dermato Venereologica. 96(217). 0–0. 5 indexed citations
15.
Ab, Smulevich, et al.. (2012). [Actual problems of systematics of depression].. PubMed. 112(11 Pt 2). 11–20. 6 indexed citations
16.
Schreiner, A., Nesrin Dılbaz, Moshe Kotler, et al.. (2010). PALIPERIDONE ER IN NON-ACUTE PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL OLANZAPINE. Schizophrenia Research. 117(2-3). 498–499. 3 indexed citations
17.
Tohen, Mauricio, Charles L. Bowden, Smulevich Ab, et al.. (2008). Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes. The British Journal of Psychiatry. 192(2). 135–143. 52 indexed citations
18.
Zhang, Lu, Ferenc Martényi, Stephen L. Lowe, et al.. (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nature Medicine. 13(9). 1102–1107. 790 indexed citations breakdown →
19.
Ab, Smulevich. (1989). Sluggish Schizophrenia in the Modern Classification of Mental Illness. Schizophrenia Bulletin. 15(4). 533–539. 17 indexed citations
20.
Ab, Smulevich, et al.. (1979). Psychopharmacotherapy of slowly progressive hypochondriacal schizophrenia. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 79(11). 1583–1587. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morozova Ma Breakdown of academic impact, for papers by Don Goff Breakdown of academic impact, for papers by А С Аведисова Breakdown of academic impact, for papers by Anne‐Noël Samaha Breakdown of academic impact, for papers by Teresa Tallerico Breakdown of academic impact, for papers by Philip Seeman Breakdown of academic impact, for papers by H. Lôo Breakdown of academic impact, for papers by Kaj Forslund Breakdown of academic impact, for papers by Lisa D. Kochan Breakdown of academic impact, for papers by George Garibaldi
Rankless by CCL
2026